Literature DB >> 8988323

Antioxidant property of Fructus Momordicae extract.

H Shi1, M Hiramatsu, M Komatsu, T Kayama.   

Abstract

The antioxidant effect of Fructus Momordicae extract, FME (mogrosides 75 approximately 80%), was studied. FME reduced the stable free radical 1,1-diphenyl-2-picrylhydrazyl (DPPH) and scavenged superoxide radicals (O2-) generated by a hypoxanthine and xanthine oxidase system. It also scavenged hydroxyl radicals (.OH) generated by Fenton reaction. In addition, FME inhibited Fe(II) induced lipid peroxidation in rat cortex homogenates in a dose-dependent manner, as indicated by decreased thiobarbituric acid-reactive substances (TBARS) formation. Oral administration of FME inhibited TBARS and malonaldehyde (MDA) formation in the ipsilateral cortex 30 min after iron-salt injection into the left cortex of rat. FME showed inhibitory effect on 4-hydroxy-2(E)-nonenal (4-HNE) formation induced by Fe(III) injection into the rat cortex. These data suggest that Fructus Momordicae extract has an antioxidant activity against free radicals and lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8988323     DOI: 10.1080/15216549600201753

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  3 in total

1.  Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.

Authors:  Pornsiri Pitchakarn; Shinobu Ohnuma; Komsak Pintha; Wilart Pompimon; Suresh V Ambudkar; Pornngarm Limtrakul
Journal:  J Nutr Biochem       Date:  2011-03-16       Impact factor: 6.048

2.  Studies on chemical fingerprints of Siraitia grosvenorii fruits (Luo Han Guo) by HPLC.

Authors:  Fenglai Lu; Dianpeng Li; Chuanming Fu; Jinlei Liu; Yonglin Huang; Yueyuan Chen; Yongxin Wen; Toshihiro Nohara
Journal:  J Nat Med       Date:  2011-06-30       Impact factor: 2.343

3.  Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells.

Authors:  Ramani Soundararajan; Punit Prabha; Umesh Rai; Aparna Dixit
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.